TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TGTX TG Therapeutics Inc.

交易中 10-02 12:28:36 EDT

22.62

-0.21

-0.92%

最高22.78	最低22.02	成交量96.73万
今开22.64	昨收22.83	日振幅3.33%
总市值35.02亿	流通市值32.80亿	总股本1.55亿
成交额2,169万	换手率0.67%	流通股本1.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":22.62,"timestamp":1727886507290,"preClose":22.83,"halted":0,"volume":967267,"delay":0,"floatShares":145000000,"shares":154823137,"eps":0.639101,"marketStatus":"交易中","marketStatusCode":2,"change":-0.21,"latestTime":"10-02 12:28:36 EDT","open":22.64,"high":22.78,"low":22.02,"amount":21694915.695228998,"amplitude":0.03329,"askPrice":22.62,"askSize":116,"bidPrice":22.6,"bidSize":40,"shortable":3,"etf":0,"ttmEps":0.639101,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1727899200000},"adr":0,"listingDate":1128657600000,"adjPreClose":22.83,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":22.61,"preClose":22.83,"latestTime":"09:29 EDT","volume":3528,"amount":79821.86083199999,"timestamp":1727875799999},"postHourTrading":{"tag":"盘后","latestPrice":22.6001,"preClose":22.83,"latestTime":"19:59 EDT","volume":44262,"amount":1010297.2564,"timestamp":1727827196883},"volumeRatio":0.931848,"impliedVol":0.7206,"impliedVolPercentile":0.2976},"requestUrl":"/m/hq/s/TGTX/wiki","defaultTab":"wiki","newsList":[{"id":"2469147531","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.07%报23.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469147531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469147531?lang=zh_cn&edition=full","pubTime":"2024-09-24 00:42","pubTimestamp":1727109721,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日00时42分，Tg Therapeutics, Inc.股票出现波动，股价急速下挫5.07%。截至发稿，该股报23.40美元/股，成交量131.948万股，换手率0.85%，振幅5.52%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.72%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004202ab656237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004202ab656237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","LENZ","TGTX"],"gpt_icon":0},{"id":"2468462165","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468462165?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:13","pubTimestamp":1726841593,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时13分，Tg Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221313a1db75b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221313a1db75b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4588","LENZ","BK4585","BK4139"],"gpt_icon":0},{"id":"2460444262","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460444262","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460444262?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:38","pubTimestamp":1723826293,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日00时38分，Tg Therapeutics, Inc.股票出现波动，股价快速拉升5.11%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为8080.83%、1950.65%、1078.15%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.，振幅分别为259.26%、176.25%、69.25%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700381398e3533b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700381398e3533b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","BK4139","BK4585","LENZ"],"gpt_icon":0},{"id":"2459727314","title":"Tg Therapeutics, Inc.2024财年第二财季实现净利润6.88百万美元，同比增加114.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459727314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459727314?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:01","pubTimestamp":1723737687,"startTime":"0","endTime":"0","summary":"8月16日，Tg Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为6.88百万美元，同比增加114.45%；其中营业收入为73.47百万美元，同比增加357.19%，每股基本收益为0.05美元。机构评级：截至2024年8月16日，当前有8家机构对Tg Therapeutics, Inc.目标价做出预测，其中目标均价为33.75美元，其中最低目标价为8.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160001329f2e430a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160001329f2e430a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ"],"gpt_icon":0},{"id":"1146587292","title":"异动解读 | TG Therapeutics股价大涨5.66% 生物技术行业表现抢眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1146587292","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146587292?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:56","pubTimestamp":1723471016,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.今日盘中股价大涨5.66%,引发市场关注。根据公开消息,该公司最新财报显示营收和净利润均有不错表现,每股收益0.05美元,毛利率也达到了65.09%。从行业层面来看,TG Therapeutics所在的生物技术行业今日整体表现较为抢眼,多只个股出现上涨。其中,Revance Therapeutics、Reviva Pharmaceuticals和Coeptis Therapeutics涨幅较大;Oragenics、Revance Therapeutics和60 Degrees Pharmaceuticals活跃度较高,换手率和振幅均处于较高水平。机构方面,78%的分析师给予TG Therapeutics\"买入\"评级,看好公司前景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"2458627986","title":"Tg Therapeutics, Inc.盘中异动 急速拉升5.17%报20.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458627986","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458627986?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:39","pubTimestamp":1723469940,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时39分，Tg Therapeutics, Inc.股票出现波动，股价大幅拉升5.17%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为53.00%、26.85%、22.95%，振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为30.36%、22.55%、21.44%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213900aefe6b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213900aefe6b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","TGTX","BK4585","LENZ"],"gpt_icon":0},{"id":"2457484461","title":"Tg Therapeutics, Inc.盘中异动 快速拉升5.39%报21.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457484461","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457484461?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037498,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Tg Therapeutics, Inc.股票出现异动，股价快速拉升5.39%。截至发稿，该股报21.69美元/股，成交量13.6387万股，换手率0.09%，振幅1.55%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213138aefdba03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213138aefdba03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","TGTX","BK4588","BK4139"],"gpt_icon":0},{"id":"1157651084","title":"异动解读 | TG Therapeutics上调多发性硬化症药物销售预期 股价大涨近21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157651084","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157651084?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:35","pubTimestamp":1722954900,"startTime":"0","endTime":"0","summary":"制药公司TG Therapeutics(TGTX)今日股价在盘中大涨20.92%,引发市场广泛关注。这主要受到公司上调其多发性硬化症药物Briumvi 2024年销售预期的利好消息推动。\n\nTG Therapeutics将Briumvi 2024年产品净销售额预期从之前的2.7亿至2.9亿美元上调至2.9亿至3亿美元。这一调整反映了公司对该药物未来销售前景的乐观预期,增强了投资者对公司长期增长潜力的信心。\n\n除此之外,公司第二季度收入同比大幅增长,现金储备充裕,并设立了新的2.5亿美元信贷额度,为未来发展提供了资金支持。这些利好因素也在一定程度上推动了股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"1107481092","title":"异动解读 | TG Therapeutics上调多发性硬化症药物销售预期 股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1107481092","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107481092?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:50","pubTimestamp":1722945015,"startTime":"0","endTime":"0","summary":"制药公司TG Therapeutics(TGTX)股价在盘前大涨19.06%,主要受到公司上调其多发性硬化症药物Briumvi 2024年销售预期的利好消息推动。\n\nTG Therapeutics将Briumvi 2024年产品净销售额预期从之前的2.7亿至2.9亿美元上调至2.9亿至3亿美元。这一调整反映了公司对该药物未来销售前景的乐观预期。\n\n此外,公司第二季度收入同比大幅增长,现金储备充裕,并设立了新的2.5亿美元信贷额度,为未来发展提供了资金支持。这些因素也在一定程度上推动了股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"2457434690","title":"BUZZ-TG Therapeutics上调其多发性硬化症药物的财政年度销售预期后，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2457434690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457434690?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:46","pubTimestamp":1722944786,"startTime":"0","endTime":"0","summary":"    8月6日 - ** 制药商TG Therapeutics   股价盘前上涨17.6%至20.23美元 ** 该公司将其多发性硬化症药物Briumvi的2024年产品净销售额预期上调至2.9亿至3亿美元，而之前的预期区间为2.7亿至2.9亿美元。** 截至最后收盘，该公司股票今年以来基本持平","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","LENZ","BK4585","BK4139","TG","BK4588","BUZZ","TGTX","BK4153"],"gpt_icon":0},{"id":"2457730257","title":"Tg Therapeutics, Inc.盘中异动 股价大跌7.19%报17.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457730257","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457730257?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722865012,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分，Tg Therapeutics, Inc.股票出现异动，股价快速下挫7.19%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1051.90%、47.05%、14.00%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213652957f3119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213652957f3119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","BK4139","TGTX","BK4588"],"gpt_icon":0},{"id":"2456435021","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.01%报18.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456435021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456435021?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:01","pubTimestamp":1722520896,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时01分，Tg Therapeutics, Inc.股票出现异动，股价快速跳水5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为191.78%、157.23%、71.08%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Immuneering Corporation、Biomea Fusion, Inc.，振幅分别为40.35%、29.20%、27.92%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220136aefcb6b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220136aefcb6b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2456166015","title":"Tg Therapeutics, Inc.盘中异动 大幅拉升5.00%报20.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456166015","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456166015?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:49","pubTimestamp":1722451773,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时49分，Tg Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为729.94%、169.08%、156.23%，振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为89.73%、79.10%、52.94%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408010249339682259c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408010249339682259c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","LENZ","TGTX"],"gpt_icon":0},{"id":"2455572329","title":"Tg Therapeutics, Inc.盘中异动 急速下跌5.01%报18.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455572329","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455572329?lang=zh_cn&edition=full","pubTime":"2024-07-31 00:08","pubTimestamp":1722355731,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日00时08分，Tg Therapeutics, Inc.股票出现异动，股价快速下挫5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Imunon, Inc.、Processa Pharmaceuticals, Inc.、Pharming Group Nv涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1875.59%、1362.54%、1199.70%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、55.88%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731000851aefc369f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731000851aefc369f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","LENZ","BK4139","TGTX"],"gpt_icon":0},{"id":"2454293983","title":"TG Therapeutics Inc   预计每股亏损5美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2454293983","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454293983?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:54","pubTimestamp":1722005671,"startTime":"0","endTime":"0","summary":"   * TG Therapeutics Inc    预计将于7月30日公布截至2024年6月30日的季度业绩()    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于北卡罗来纳州莫里斯维尔的公司的营收有望从去年同期的1607万美元增长309.9%，达到6589.3万美元。* LSEG 分析师对 TG Therapeutics Inc 的平均预期是每股亏损 5 美分。* 华尔街对 TG Therapeutics Inc 的 12 个月目标价中位数为 34.50 美元，高于其最新收盘价 19.98 美元。7月26日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","TGTX","TG"],"gpt_icon":0},{"id":"2452455500","title":"Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452455500","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452455500?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:51","pubTimestamp":1721328674,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时51分，Tg Therapeutics, Inc.股票出现异动，股价快速下跌5.07%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3276.29%、2674.63%、1308.05%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190251149681e242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190251149681e242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","TGTX","LENZ","BK4588"],"gpt_icon":0},{"id":"2451175913","title":"Tg Therapeutics, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451175913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451175913?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:10","pubTimestamp":1721139052,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时10分，Tg Therapeutics, Inc.股票出现异动，股价快速上涨5.03%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1858.43%、1081.99%、99.09%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.、Scisparc Ltd.，振幅分别为48.60%、43.93%、40.48%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221052941f7747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221052941f7747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4139","BK4585"],"gpt_icon":0},{"id":"2448911069","title":"Tg Therapeutics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448911069","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448911069?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:53","pubTimestamp":1719845622,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时53分，Tg Therapeutics, Inc.股票出现波动，股价快速上涨5.28%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为529.07%、142.31%、99.60%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、65.56%、51.91%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225342941f2c49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701225342941f2c49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","LENZ","BK4588","TGTX"],"gpt_icon":0},{"id":"2446319389","title":"Tg Therapeutics, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446319389","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446319389?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:48","pubTimestamp":1719420524,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时48分，Tg Therapeutics, Inc.股票出现波动，股价急速跳水5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627004844af8f5b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627004844af8f5b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4585","BK4588","LENZ","BK4139"],"gpt_icon":0},{"id":"2446784117","title":"Tg Therapeutics, Inc.盘中异动 快速上涨5.05%报19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446784117","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446784117?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:45","pubTimestamp":1719323108,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时45分，Tg Therapeutics, Inc.股票出现异动，股价大幅上涨5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Effector Therapeutics, Inc.涨幅较大，Glycomimetics, Inc.、Effector Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为113.56%、93.54%、68.91%，振幅较大的相关个股有Werewolf Therapeutics, Inc.、Glycomimetics, Inc.、Cingulate Inc.，振幅分别为29.12%、23.37%、19.77%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521450896816a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521450896816a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","TGTX","BK4588","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":-0.0281},{"period":"3month","weight":0.215},{"period":"6month","weight":0.5788},{"period":"1year","weight":1.7978},{"period":"ytd","weight":0.3367}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0311},{"period":"6month","weight":0.1083},{"period":"1year","weight":0.3307},{"period":"ytd","weight":0.1963}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司，专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外，TG还获得了美国食品药品监督管理局（FDA）的BRIUMVI（ublituximab-xiiy）批准，用于治疗成人复发性多发性硬化症（RMS）患者，包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.055658},{"month":2,"riseRate":0.727273,"avgChangeRate":0.087019},{"month":3,"riseRate":0.636364,"avgChangeRate":0.095138},{"month":4,"riseRate":0.363636,"avgChangeRate":0.008444},{"month":5,"riseRate":0.545455,"avgChangeRate":0.017012},{"month":6,"riseRate":0.5,"avgChangeRate":0.057765},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.000866},{"month":8,"riseRate":0.583333,"avgChangeRate":-0.018713},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.054488},{"month":10,"riseRate":0.25,"avgChangeRate":-0.071039},{"month":11,"riseRate":0.909091,"avgChangeRate":0.172914},{"month":12,"riseRate":0.545455,"avgChangeRate":0.134525}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}